Index S&P 500 P/E 7.59 EPS (ttm) 10.47 Insider Own 2.28% Shs Outstand 93.79M Perf Week 1.12%
Market Cap 7.47B Forward P/E 6.18 EPS next Y 12.85 Insider Trans -4.17% Shs Float 91.89M Perf Month -28.81%
Income 1.00B PEG 0.51 EPS next Q 2.90 Inst Own 83.39% Short Float 3.73% Perf Quarter -35.29%
Sales 5.54B P/S 1.35 EPS this Y 9.99% Inst Trans -0.08% Short Ratio 1.25 Perf Half Y -29.89%
Book/sh 47.84 P/B 1.66 EPS next Y 9.70% ROA 3.62% Short Interest 3.43M Perf Year -27.09%
Cash/sh - P/C - EPS next 5Y 14.89% ROE 20.69% 52W Range 38.95 - 132.00 Perf YTD -34.70%
Dividend Est. 0.90 (1.13%) P/FCF 5.22 EPS past 5Y 10.60% ROI 16.37% 52W High -39.79% Beta 0.78
Dividend TTM 0.92 (1.15%) Quick Ratio - Sales past 5Y 4.84% Gross Margin - 52W Low 104.06% ATR (14) 6.13
Dividend Ex-Date Apr 04, 2024 Current Ratio 0.80 EPS Y/Y TTM 28.86% Oper. Margin 24.50% RSI (14) 43.89 Volatility 6.46% 13.86%
Employees 3636 Debt/Eq 0.47 Sales Y/Y TTM 6.02% Profit Margin 18.07% Recom 2.00 Target Price 106.70
Option/Short Yes / Yes LT Debt/Eq 0.36 EPS Q/Q 16.91% Payout 8.93% Rel Volume 0.90 Prev Close 76.17
Sales Surprise -0.61% EPS Surprise -0.30% Sales Q/Q 7.18% Earnings Apr 22 AMC Avg Volume 2.75M Price 79.48
SMA20 -0.35% SMA50 -24.23% SMA200 -30.06% Trades
Volume 2,466,570 Change 4.35%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-24-24 Upgrade Keefe Bruyette
Mkt Perform → Outperform
$130 → $110
Oct-31-23 Upgrade Wells Fargo
Equal Weight → Overweight
$122 → $137
Aug-18-23 Upgrade Morgan Stanley
Underweight → Equal-Weight
$131
Apr-25-23 Initiated Wells Fargo
Equal Weight
$120
Oct-28-22 Downgrade Evercore ISI
Outperform → In-line
$115 → $114
Sep-22-22 Initiated Raymond James
Strong Buy
$138
Jun-15-22 Upgrade Evercore ISI
In-line → Outperform
$105 → $112
Jan-26-22 Initiated Jefferies
Hold
$106
Jan-21-22 Initiated Wolfe Research
Underperform
$85
Jan-12-22 Upgrade Piper Sandler
Neutral → Overweight
$105 → $117
Jul-24-20 Upgrade Evercore ISI
Underperform → In-line
Jun-05-20 Initiated Piper Sandler
Neutral
$87
Sep-20-19 Initiated Credit Suisse
Outperform
$114
Show Previous Ratings
Today 09:30AM
Apr-30-24 02:18PM
Apr-29-24 10:10AM
09:22AM
07:00AM
10:09AM
Loading…
Apr-26-24 10:09AM
Apr-24-24 11:36AM
09:36AM
08:25AM
Apr-23-24 04:41PM
01:51PM
11:35AM
07:20AM
Apr-22-24 08:53PM
06:49PM
06:11PM
Loading…
06:11PM
06:00PM
05:25PM
05:13PM
05:06PM
04:26PM
(Associated Press Finance)
04:15PM
02:57PM
10:26AM
09:35AM
Apr-19-24 10:14AM
09:40AM
08:48AM
07:00AM
Apr-18-24 03:01PM
01:21PM
Loading…
01:21PM
Apr-17-24 04:43PM
12:50PM
09:15AM
06:15AM
Apr-16-24 05:50PM
12:46PM
Apr-15-24 05:13PM
11:13AM
10:48AM
10:00AM
08:47AM
Apr-12-24 05:02PM
04:07PM
02:45PM
01:57PM
(The Wall Street Journal)
12:10PM
11:47AM
11:01AM
10:49AM
10:20AM
10:16AM
(The Wall Street Journal)
07:48AM
Apr-11-24 06:25PM
06:01PM
05:39PM
05:28PM
05:02PM
04:35PM
04:00PM
03:26PM
(The Wall Street Journal)
03:19PM
11:58AM
11:27AM
09:13AM
09:06AM
Apr-10-24 09:17AM
Apr-09-24 11:14AM
09:55AM
Apr-04-24 07:26AM
Apr-03-24 11:45AM
09:40AM
Mar-18-24 04:10PM
Mar-15-24 05:06AM
Mar-08-24 11:30AM
08:15AM
Feb-29-24 12:04AM
Feb-13-24 09:15AM
Feb-09-24 12:00PM
02:30AM
(Thomson Reuters StreetEvents)
Feb-08-24 08:42AM
Feb-07-24 06:00PM
05:54PM
05:25PM
04:53PM
04:34PM
(Associated Press Finance)
04:15PM
Feb-06-24 12:10PM
Feb-05-24 09:16AM
07:00AM
Jan-31-24 10:00AM
Jan-25-24 06:21PM
Jan-23-24 01:04PM
Jan-16-24 08:05AM
Dec-20-23 09:40AM
Dec-13-23 04:42AM
Dec-06-23 07:45AM
Dec-01-23 07:10AM
Nov-28-23 09:55AM
Nov-24-23 11:31AM
Globe Life, Inc. is a holding company, which engages in the provision of individual life and supplemental health insurance products and services. It operates through the following segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments. The Life Insurance segment includes traditional and interest-sensitive whole life insurance as well as term life insurances. The Supplement Health Insurance segment provides generally guaranteed-renewable and include Medicare, critical illness, accident, and limited-benefit supplement hospital, and surgical coverage. The Annuities segment refers to fixed-benefit contracts. The Investments segment covers the investment portfolio. The company was founded on November 19, 1979, and is headquartered in McKinney, TX.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
BLINN MARK A Director Apr 25 '24 Buy 76.77 2,000 153,540 6,518 Apr 26 02:56 PM Zorn Rebecca E EVP & Chief Talent Officer Apr 25 '24 Sale 77.30 2,320 179,336 10,220 Apr 26 12:45 PM BRANNEN JAMES Director Apr 24 '24 Buy 78.47 2,000 156,940 7,030 Apr 26 12:14 PM Rodriguez David A Director Apr 24 '24 Buy 79.72 1,500 119,585 4,192 Apr 26 12:33 PM Johnson Steven Paul Director Apr 24 '24 Buy 76.42 1,319 100,800 14,766 Apr 26 12:29 PM Haworth Jennifer Allison EVP & Chief Marketing Officer Dec 29 '23 Option Exercise 50.69 4,500 228,120 11,130 Dec 29 03:51 PM Haworth Jennifer Allison EVP & Chief Marketing Officer Dec 29 '23 Sale 121.37 2,524 306,348 8,606 Dec 29 03:51 PM BUCHAN JANE Director Dec 12 '23 Sale 124.50 1,000 124,500 80,285 Dec 13 04:47 PM Skarjune Dolores L EVP and Chief Admin. Officer Dec 11 '23 Option Exercise 95.05 23,775 2,259,780 25,435 Dec 12 12:56 PM Skarjune Dolores L EVP and Chief Admin. Officer Dec 11 '23 Sale 123.28 20,479 2,524,565 4,956 Dec 12 12:56 PM Zorn Rebecca E EVP & Chief Talent Officer Nov 30 '23 Option Exercise 82.70 18,500 1,529,880 22,442 Dec 01 04:16 PM Zorn Rebecca E EVP & Chief Talent Officer Nov 30 '23 Sale 122.08 13,990 1,707,910 8,452 Dec 01 04:16 PM MAJORS MICHAEL CLAY EVP - Chief Strategy Officer Nov 21 '23 Option Exercise 83.23 15,000 1,248,480 50,015 Nov 22 10:07 AM MAJORS MICHAEL CLAY EVP - Chief Strategy Officer Nov 21 '23 Sale 119.36 15,000 1,790,424 35,015 Nov 22 10:07 AM SVOBODA FRANK M Co-Chairman & CEO Nov 17 '23 Option Exercise 77.26 9,500 733,970 12,870 Nov 20 09:43 AM SVOBODA FRANK M Co-Chairman & CEO Nov 17 '23 Sale 118.22 9,500 1,123,056 3,370 Nov 20 09:43 AM HENRIE MICHAEL SHANE SVP & Chief Accounting Officer Nov 15 '23 Option Exercise 100.33 6,800 682,249 7,500 Nov 16 11:10 AM HENRIE MICHAEL SHANE SVP & Chief Accounting Officer Nov 15 '23 Sale 117.57 6,800 799,488 700 Nov 16 11:10 AM SVOBODA FRANK M Co-Chairman & CEO Nov 06 '23 Option Exercise 77.26 20,000 1,545,200 23,370 Nov 07 04:06 PM SVOBODA FRANK M Co-Chairman & CEO Nov 06 '23 Sale 115.92 20,000 2,318,496 3,370 Nov 07 04:06 PM Darden James Matthew Co-Chairman & CEO Nov 03 '23 Option Exercise 77.26 9,551 737,910 34,621 Nov 06 05:27 PM Darden James Matthew Co-Chairman & CEO Nov 03 '23 Sale 116.98 8,551 1,000,289 26,070 Nov 06 05:27 PM HENRIE MICHAEL SHANE SVP & Chief Accounting Officer Oct 27 '23 Option Exercise 98.32 2,500 245,800 3,200 Oct 31 11:22 AM HENRIE MICHAEL SHANE SVP & Chief Accounting Officer Oct 27 '23 Sale 113.05 2,500 282,630 700 Oct 31 11:22 AM HENRIE MICHAEL SHANE SVP & Chief Accounting Officer Sep 12 '23 Option Exercise 98.32 2,500 245,800 3,200 Sep 13 05:52 PM HENRIE MICHAEL SHANE SVP & Chief Accounting Officer Sep 12 '23 Sale 110.37 2,500 275,926 700 Sep 13 05:52 PM MITCHELL ROBERT BRIAN EVP, General Counsel and CRO Aug 30 '23 Sale 111.97 16,217 1,815,766 36,635 Aug 31 04:08 PM HENRIE MICHAEL SHANE SVP & Chief Accounting Officer Aug 29 '23 Option Exercise 93.55 1,325 123,954 2,025 Aug 30 12:32 PM HENRIE MICHAEL SHANE SVP & Chief Accounting Officer Aug 29 '23 Sale 111.20 1,325 147,335 700 Aug 30 12:32 PM SVOBODA FRANK M Co-Chairman & CEO Aug 16 '23 Option Exercise 77.26 12,500 965,750 15,870 Aug 17 05:58 PM SVOBODA FRANK M Co-Chairman & CEO Aug 16 '23 Sale 113.57 12,500 1,419,574 3,370 Aug 17 05:58 PM HENRIE MICHAEL SHANE SVP & Chief Accounting Officer Jul 31 '23 Option Exercise 87.60 1,000 87,600 1,700 Aug 01 11:17 AM HENRIE MICHAEL SHANE SVP & Chief Accounting Officer Jul 31 '23 Sale 112.06 1,000 112,060 700 Aug 01 11:17 AM Alston Cheryl Director Jun 14 '23 Option Exercise 79.31 16,691 1,323,767 22,929 Jun 15 05:03 PM Alston Cheryl Director Jun 14 '23 Sale 108.81 16,691 1,816,184 6,238 Jun 15 05:03 PM
Index - P/E - EPS (ttm) -0.90 Insider Own 47.54% Shs Outstand 19.92M Perf Week 1.88%
Market Cap 57.29M Forward P/E - EPS next Y -1.01 Insider Trans 0.45% Shs Float 13.85M Perf Month -26.19%
Income -15.43M PEG - EPS next Q - Inst Own 8.67% Short Float 2.53% Perf Quarter -43.19%
Sales 0.00M P/S - EPS this Y -24.00% Inst Trans 19.81% Short Ratio 1.38 Perf Half Y -34.44%
Book/sh 0.82 P/B 2.64 EPS next Y -8.60% ROA -88.57% Short Interest 0.35M Perf Year -24.13%
Cash/sh 0.66 P/C 3.27 EPS next 5Y - ROE -104.35% 52W Range 1.40 - 7.75 Perf YTD -68.64%
Dividend Est. - P/FCF - EPS past 5Y -63.30% ROI -94.03% 52W High -72.00% Beta 0.24
Dividend TTM - Quick Ratio 5.32 Sales past 5Y 0.00% Gross Margin - 52W Low 55.00% ATR (14) 0.27
Dividend Ex-Date - Current Ratio 5.32 EPS Y/Y TTM -48.76% Oper. Margin 0.00% RSI (14) 34.34 Volatility 12.75% 11.61%
Employees 17 Debt/Eq 0.00 Sales Y/Y TTM - Profit Margin - Recom 1.00 Target Price 14.00
Option/Short Yes / Yes LT Debt/Eq 0.00 EPS Q/Q 11.04% Payout - Rel Volume 0.22 Prev Close 2.17
Sales Surprise - EPS Surprise - Sales Q/Q - Earnings - Avg Volume 253.41K Price 2.17
SMA20 -13.51% SMA50 -24.33% SMA200 -38.28% Trades
Volume 55,808 Change 0.00%
Apr-29-24 02:50PM
09:39AM
Apr-18-24 09:37AM
09:32AM
Apr-15-24 09:36AM
07:53AM
Loading…
Apr-02-24 07:53AM
Mar-20-24 09:46AM
Mar-05-24 09:35AM
Feb-21-24 09:31AM
Feb-08-24 04:45PM
Feb-07-24 09:37AM
Feb-05-24 10:30PM
03:20PM
Jan-24-24 08:35AM
Jan-04-24 09:34AM
09:39AM
Loading…
Dec-18-23 09:39AM
Dec-11-23 09:36AM
Nov-30-23 09:46AM
Nov-28-23 08:50AM
Nov-22-23 11:10AM
09:19AM
Nov-21-23 09:46AM
Nov-06-23 09:18AM
09:12AM
08:40AM
Oct-31-23 09:55AM
Oct-26-23 08:58AM
Oct-16-23 09:05AM
Oct-03-23 09:14AM
Oct-02-23 08:06AM
12:04PM
Loading…
Sep-22-23 12:04PM
Sep-21-23 08:55AM
Sep-19-23 09:10AM
Sep-15-23 01:18PM
Sep-07-23 10:38AM
08:41AM
Sep-01-23 08:39AM
Aug-23-23 08:37AM
Aug-18-23 09:20AM
Aug-16-23 09:05AM
Jul-25-23 08:42AM
Jul-17-23 09:37AM
Jul-10-23 09:47AM
Jun-26-23 09:49AM
Jun-22-23 09:53AM
Jun-20-23 09:45AM
Jun-16-23 09:43AM
Jun-14-23 07:30AM
Jun-12-23 09:49AM
May-26-23 09:53AM
May-22-23 01:48PM
08:31AM
May-21-23 04:05PM
04:00PM
May-04-23 12:30PM
May-03-23 04:42PM
08:00AM
Apr-26-23 05:30PM
Apr-04-23 08:00AM
Mar-31-23 08:00AM
Mar-23-23 08:00AM
Mar-10-23 07:45PM
Mar-06-23 08:00AM
Feb-27-23 08:45AM
Feb-15-23 08:30AM
Feb-09-23 08:00AM
Feb-07-23 08:00AM
Jan-13-23 08:00AM
Jan-06-23 08:00AM
Dec-28-22 08:00AM
Dec-20-22 08:00AM
Dec-19-22 08:00AM
Dec-14-22 12:43PM
08:00AM
Dec-13-22 08:00AM
05:06AM
Dec-12-22 08:00AM
Nov-11-22 08:00AM
Oct-25-22 08:00AM
Oct-18-22 08:00AM
Sep-07-22 12:05PM
Aug-23-22 06:36AM
Aug-01-22 10:10AM
May-21-22 08:26AM
May-20-22 10:19AM
08:47AM
May-09-22 08:00AM
Apr-05-22 09:30AM
Mar-16-22 10:13AM
(Simply Wall St.) +19.12%
Mar-07-22 08:00AM
Feb-22-22 08:00AM
Feb-01-22 11:36AM
09:30AM
Jan-31-22 08:00AM
Jan-25-22 12:17PM
10:15AM
Jan-19-22 08:00AM
Jan-12-22 08:43AM
08:00AM
Jan-06-22 09:00AM
Immix Biopharma, Inc. operates as a biopharmaceutical company that engages in the development of therapies for cancer and inflammatory diseases. The company was founded by Ilya Rachman, Sean Senn, and Vladimir Torchilin in 2012 and is headquartered in Los Angeles, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Hsu Jason Director Dec 11 '23 Buy 4.67 31,000 144,894 813,000 Dec 12 06:25 PM Hsu Jason Director Dec 08 '23 Buy 4.88 25,000 122,025 782,000 Dec 12 06:25 PM Hsu Jason Director Sep 15 '23 Buy 2.49 7,000 17,396 757,000 Sep 18 07:03 PM Hsu Jason Director Sep 14 '23 Buy 2.58 10,000 25,772 750,000 Sep 18 07:03 PM Ng Carey Director Sep 14 '23 Buy 2.58 10,000 25,760 10,000 Sep 15 06:27 PM Hsu Jason Director Sep 12 '23 Buy 2.83 30,000 84,864 740,000 Sep 18 07:03 PM Adams Helen C. Director Sep 12 '23 Buy 2.96 13,000 38,492 13,000 Sep 14 05:20 PM Hsu Jason Director Sep 11 '23 Buy 2.89 25,000 72,280 710,000 Sep 18 07:03 PM Hsu Jason Director Sep 08 '23 Buy 2.53 10,000 25,317 685,000 Sep 12 04:58 PM BUCHAN MELISSA JANE Director Sep 07 '23 Buy 2.46 20,000 49,226 20,000 Sep 11 05:18 PM Marquet Magda Director Sep 06 '23 Buy 2.47 9,000 22,213 20,000 Sep 08 05:46 PM Marquet Magda Director Sep 05 '23 Buy 2.47 10,000 24,722 11,000 Sep 06 04:33 PM Marquet Magda Director Aug 31 '23 Buy 2.01 1,000 2,010 1,000 Sep 05 06:43 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite
